医学
甲状腺结节
甲状腺癌
甲状腺
甲状腺髓样癌
甲状腺间变性癌
放射治疗
癌症
放射科
肿瘤科
内科学
摘要
During the past 5 years, there have been many important advances in the diagnosis of thyroid nodules and the management of thyroid cancer. The development of fineneedle aspiration-derived, molecular marker panels has aided in the appropriate selection of cytologically indeterminate thyroid nodules for surgical treatment. Recently, expert consensus panels have published evidence-based guidelines for the medical and surgical management of thyroid nodules, as well as both differentiated and medullary thyroid cancers. Additionally, these guidelines have delineated a more rational approach than in the past for the decision to use radioiodine ablation based on risk versus benefit, and for metastatic thyroid cancer, both empiric and dosimetric recommendations have been described. For advancing or invasive differentiated thyroid cancer and anaplastic thyroid cancer, there have been innovations for palliation in both external beam radiotherapy and medical oncology.
科研通智能强力驱动
Strongly Powered by AbleSci AI